New eczema drug ZL-1503 enters first human safety trials
NCT ID NCT07235384
First seen Nov 19, 2025 · Last updated May 15, 2026 · Updated 15 times
Summary
This early-stage study tests whether a new medicine called ZL-1503 is safe for people with moderate to severe atopic dermatitis (eczema). About 84 healthy volunteers and eczema patients will receive either the drug or a placebo. Researchers will monitor for side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ZaiLab Site 18001
RECRUITINGAuckland, Auckland, New Zealand
Conditions
Explore the condition pages connected to this study.